| Date Filed | Type | Description |
| 08/15/2023 |
4
| BOYER ANDREW S (Executive Vice President) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Sold 29,302 shares
@ $4.1267, valued at
$120.9k
|
|
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2023 |
4
| BOYER ANDREW S (Executive Vice President) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 11,571 shares
@ $3.1, valued at
$35.9k
Exercised 23,095 restricted stock units
@ $0 |
|
| 05/11/2023 |
4
| MEISTER PAUL M (Director) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Granted 107,034 restricted stock units
@ $0
Exercised 112,179 restricted stock units
@ $0 |
|
| 05/11/2023 |
4
| Alva Emily Peterson (Director) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Granted 76,453 restricted stock units
@ $0
Exercised 80,128 restricted stock units
@ $0 |
|
| 05/11/2023 |
4
| Autor Deborah M. (Director) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Granted 76,453 restricted stock units
@ $0 |
|
| 05/11/2023 |
4
| Kiely John (Director) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Granted 76,453 restricted stock units
@ $0
Exercised 80,128 restricted stock units
@ $0 |
|
| 05/11/2023 |
4
| Yanai Shlomo (Director) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Granted 76,453 restricted stock units
@ $0
Exercised 80,128 restricted stock units
@ $0 |
|
| 05/11/2023 |
4
| BUCHI J KEVIN (Director) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Granted 76,453 restricted stock units
@ $0
Exercised 80,128 restricted stock units
@ $0 |
|
| 05/11/2023 |
4
| Patel Gautam (Director) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Granted 76,453 restricted stock units
@ $0
Exercised 80,128 restricted stock units
@ $0 |
|
| 05/11/2023 |
4
| George Jeffrey P. (Director) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Granted 76,453 restricted stock units
@ $0
Exercised 80,128 restricted stock units
@ $0 |
|
| 05/11/2023 |
4
| Nark Ted C (Director) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Granted 76,453 restricted stock units
@ $0
Exercised 80,128 restricted stock units
@ $0 |
|
| 03/14/2023 |
4
| Konidaris Tasos (Executive Vice President & CFO) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Exercised 87,719 restricted stock units
@ $0 |
|
| 03/07/2023 |
4
| Shah Nikita (Executive Vice President) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 18,064 shares
@ $1.92, valued at
$34.7k
Exercised 36,232 restricted stock units
@ $0
Granted 183,486 restricted stock units
@ $0
Granted 366,972 options to buy
@ $0 |
|
| 03/07/2023 |
4
| Konidaris Tasos (Executive Vice President & CFO) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Exercised 45,289 restricted stock units
@ $0
Granted 229,358 restricted stock units
@ $0
Granted 458,716 options to buy
@ $0 |
|
| 03/07/2023 |
4
| Patel Chintu (Co-CEO) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Granted 733,944 options to buy
@ $0 |
|
| 03/07/2023 |
4
| Patel Chirag K. (President & Co-CEO) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Granted 733,944 options to buy
@ $0 |
|
| 03/07/2023 |
4
| BOYER ANDREW S (Executive Vice President) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 19,685 shares
@ $1.92, valued at
$37.8k
Exercised 39,251 restricted stock units
@ $0
Granted 198,777 restricted stock units
@ $0
Granted 397,554 options to buy
@ $0 |
|
| 03/07/2023 |
4
| Daly Jason B. (SVP, Chief Legal Officer) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 8,164 shares
@ $1.92, valued at
$15.7k
Exercised 22,645 restricted stock units
@ $0
Granted 152,905 restricted stock units
@ $0
Granted 305,810 options to buy
@ $0 |
|
| 03/01/2023 |
4
| BOYER ANDREW S (Executive Vice President) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 17,557 shares
@ $2.16, valued at
$37.9k
Exercised 31,662 restricted stock units
@ $0 |
|
| 03/01/2023 |
4
| Shah Nikita (Executive Vice President) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 19,752 shares
@ $2.16, valued at
$42.7k
Exercised 35,620 restricted stock units
@ $0 |
|
| 12/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/08/2022 |
4
| Pesquin Gustavo (See Remarks) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Granted 444,444 restricted stock units
@ $0 |
|
| 09/08/2022 |
3
| Pesquin Gustavo (See Remarks) has filed a Form 3 on Amneal Pharmaceuticals, Inc. |
| 08/02/2022 |
4
| Autor Deborah M. (Director) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Granted 54,949 restricted stock units
@ $0 |
|
| 08/02/2022 |
3
| Autor Deborah M. (Director) has filed a Form 3 on Amneal Pharmaceuticals, Inc. |
| 07/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/10/2022 |
4
| Patel Gautam (Director) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Exercised 35,406 restricted stock units
@ $0
Granted 80,128 restricted stock units
@ $0 |
|
| 05/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/10/2022 |
4
| Shah Nikita (Executive Vice President) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 2,228 shares
@ $3.4, valued at
$7.6k
Exercised 4,442 restricted stock units
@ $0 |
|
| 05/10/2022 |
4
| Alva Emily Peterson (Director) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Exercised 35,406 restricted stock units
@ $0
Granted 80,128 restricted stock units
@ $0 |
|
| 05/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|